|
Real-time Estimate
Cboe BZX
01:29:59 02/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 407.36 USD | -3.36% |
|
+0.63% | +24.83% |
| 30/09 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 28/09 | Scotiabank Raises Amgen Price Target to $500 From $450, Sector Outperform Rating Kept | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -3.09% | +0.63% | +24.83% | +36.88% | +91.00% | 23TCr |  | |  |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
